Moderator: Joanne Hatchett, RN, MS, FNP-retired, Medical Science Liaison, PSC Partners Seeking a Cure
Matt Frankel, MD, MBA: Chemomab Therapeutics - Chief Medical Officer, Vice President of Drug Development
Shirley Dehn: Escient Pharmaceuticals - Associate Director of Clinical Science
Anthony Loizides, MD: Ipsen Biopharmaceuticals - Medical Director of Clinical Development
Ikenna Okechukwu, MD: Ipsen Biopharmaceuticals - Medical Development Director
Chris Peetz: Mirum Pharmaceuticals, Inc. - President & Chief Executive Officer
Richard Pencek, PhD: Pliant Pharmaceuticals - Senior Director, Clinical Development
These five clinical-trial leaders each presented their company's on-going PSC study.
Негізгі бет 2023 PSC Partners Conference Session: Clinical Trial Landscape in PSC -- Updates & Opportunities
Пікірлер